Mithra Pharmaceuticals SA - Company Profile
Powered by
All the data and insights you need on Mithra Pharmaceuticals SA in one report.
- Save hours of research time and resources with
our up-to-date Mithra Pharmaceuticals SA Strategy Report
- Understand Mithra Pharmaceuticals SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Mithra Pharmaceuticals SA (Mithra) is a biotech company that develops and manufactures over the counter products for women’s health and other applications. The company offers various drug products including Donesta, Estelle, tibelia, myring and zoreline. Mithra offers its products in polymeric forms, hormonal tablets, and sterile injectable products. The company also provides CDMO services such as drug development and supporting services. It offers its products under various brands including Tibelia, Estelle and Donesta. Its products are used in the treatment of contraception and fertility, gynecological infections, menopause and osteoporosis and cancers. The company offers its products through a network of distributors in Belgium, France, Germany, Luxemburg and Brazil. Mithra is headquartered in Liege, Belgium.
Mithra Pharmaceuticals SA premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Estetrol: | Drug Development | Myring |
Estelle - Contraception | Pharmaceutical Development | Zoreline |
Donesta - Menopause | Stability Studies | Tibelia |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In December, the company announced the signing of a binding Head of Terms with Gedeon Richter for the development and commercialization of ESTELLE and DONESTA in China. |
2023 | Others | In November, the company granted an additional patent for NEXTSTELLIS in the US. |
2023 | Contracts/Agreements | In August, the company and Gedeon Richter Plc signed a binding supply agreement for the active pharmaceutical ingredient (API) for the combined oral contraceptive Estelle and Donesta. |
Competitor Comparison
Key Parameters | Mithra Pharmaceuticals SA | Galapagos NV | TherapeuticsMD Inc | Celyad Oncology SA | Endoceutics Inc |
---|---|---|---|---|---|
Headquarters | Belgium | Belgium | United States of America | Belgium | Canada |
City | Liege | Mechelen | Boca Raton | Mont-Saint-Guibert | Quebec City |
State/Province | Liege | - | Florida | - | Quebec |
No. of Employees | 229 | 646 | 1 | 12 | 1,200 |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Christian Homsy | Chairman | Executive Board | 2023 | 75 |
Erik Van Den Eynden | Vice Chairman | Executive Board | 2022 | - |
Jean-Michel Foidart | Director | Executive Board | 2021 | 73 |
Christophe Marechal | Co-Chief Executive Officer; Chief Financial Officer | Senior Management | 2024 | - |
Cedric Darcis | General Counsel; Chief Legal Officer | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward